B Lymphocyte Populations in the Lungs of ICU Patients on Ventilation
Official title: Pilot Study Describing B Lymphocyte Populations in the Pulmonary Microenvironment of Patients Under Mechanical Ventilation With or Without VAP (Ventilator-Associated Pneumonia)
Run by University Hospital, Limoges · NCT07436780 · Data updated 2026-11-12
This study tests the presence and roles of B lymphocytes in the lungs of adults on invasive ventilation, to see how humoral immunity relates to ventilator-associated pneumonia.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 75 (estimated) |
| Sponsor | University Hospital, Limoges Academic / other |
| Locations | 1 site (Limoges) |
| Status | Recruiting |
| Started | January 12, 2026 |
| Main results expected | July 11, 2027 |
| Study ends | July 11, 2027 |
| Registry record updated | September 24, 2026 |
| Trial ID | NCT07436780 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18 years) in the ICU on invasive mechanical ventilation for at least 5 days.
✕Probably not a fit
Patients who do not develop VAP or who have immune characteristics not captured by B cell analysis may see no direct benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study will collect endotracheal aspirates from adults in the ICU on invasive ventilation at three timepoints: at intubation, before extubation, and at VAP diagnosis if it occurs. Samples will be analyzed by flow cytometry to describe B lymphocyte populations in the pulmonary microenvironment. The goal is to better understand humoral immune responses in the setting of ventilator-associated pneumonia and host-pathogen interactions that contribute to infection. The study does not specify an intervention and aims to inform future diagnostic or therapeutic approaches by detailing immune cell profiles in the lung. Participants are adults requiring mechanical ventilation for at least five days and without infectious pneumonia or ARDS on admission.
Why it matters
Potential benefit: Enhanced understanding of lung B cell roles could inform future diagnostics or treatments for VAP.
How similar studies have gone: Few studies have detailed pulmonary B cell populations in VAP, making this largely exploratory and novel in this specific context.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patients (≥18 years old), admitted to intensive care under mechanical ventilation for an estimated duration of at least 5 days. Exclusion Criteria: * Patients admitted for an infectious pneumonia or presenting with acute respiratory distress syndrome (ARDS). Patients in aplasia (leukocytes \< 0.5 gigal/L).
Where it's running
-
CHU Limoges
Limoges, France Recruiting
Study contacts
- Principal investigator: Julien VAIDIE, Dr — University Hospital, Limoges
- Study coordinator: Safirah Akowanou
- Email: safirah.akowanou@chu-limoges.fr
- Phone: +33555058755
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Probiotics to Prevent Pneumonia in Critically Ill Kids in the PICU
We’re testing whether giving probiotics to critically ill children on a ventilator helps prevent ventilator-associated pneumonia.
-
Lactoferrin to help prevent infections in ventilated newborns
This study tests whether giving lactoferrin to ventilated neonates can help prevent ventilator-associated pneumonia and related complications.
-
Measuring breathing effort before and after removing the breathing tube
This will test a new electrical impedance method to measure breathing effort in adults on ventilators as they try breathing on their own and after the breathing tube is removed.
-
Rapid multiplex PCR on bronchoalveolar lavage to guide antibiotics for ventilator-associated pneumonia
This trial tests whether using a fast multiplex PCR on bronchoalveolar lavage samples helps doctors choose the right antibiotics sooner for adults on mechanical ventilation suspected of ventilator-associated pneumonia.
-
Using acyclovir to treat pneumonia in ventilated patients with herpes simplex virus
This study is testing if giving acyclovir to ICU patients on ventilators who have pneumonia and herpes simplex virus can help them survive better than those who don't receive the medication.
-
Standardized oral care using human milk for premature infants in the NICU
This study is trying to see if giving regular oral care using human milk can help very low birth weight babies in the NICU stay healthier and avoid complications.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.